Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

BSV vs IBB: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, BSV returned +1.0% to IBB's +37.5%, and BSV charges 0.03% to IBB's 0.44%.

askIQ about this page

askIQ about BSV and IBB

Net assets: $45.4bn on Sep 30, 2026 for Vanguard Short-Term Bond ETF, and $11.0bn on Oct 27, 2026 for iShares Biotechnology ETF.

At a glance
+1.0%
BSV total return, 1 year
+37.5%
IBB total return, 1 year
0.03%
BSV expense ratio
0.44%
IBB expense ratio

Pair scorecard

BSV costs 0.41 points a year less; their one-year returns differ by 36.5 points; BSV is 4.1 times larger.

BSV vs IBB: Differences, Returns & Fees
MeasureBSVIBB
Return
Total return, 1 year+1.0%+37.5%
Benchmark
What it tracksBloomberg U.S. 1-5 Year Government/Credit Float Adjusted IndexBiotech
Cost and size
Expense ratio0.03%0.44%
Net assets, as of Sep 30, 2026$45.4bn$11.2bn
Active share vs the S&P 50099%
Holdings
Holdings in common0%
In the S&P 500, by weight40%
Top ten holdings, share of the fund50%

Holdings in common uses holdings dated Sep 30, 2026 and Oct 27, 2026. Method

Risk and return

Apr 20, 2007 to Oct 23, 2026 · 1,018 weekly returns
BSV IBB
Return
Total return edge IBB +60.9% +699.2%
Annualized edge IBB +2.5% +11.2%
Price return edge IBB +2.0% +665.1%
Risk
Volatility edge BSV 2.3% 22.9%
Max drawdown edge BSV −8.1% −37.5%
Risk-adjusted
Sharpe edge IBB 0.40 0.51
Sortino edge IBB 0.58 0.73
Calmar edge Tie 0.30 0.30
Reading

IBB returned more: +699.2% to +60.9%. BSV swung less: 2.3% to 22.9%. BSV fell less at its worst: −8.1% to −37.5%.

Full scorecard

9 measures, with how each is measured
Open ↓
Risk and return: BSV vs IBB: Differences, Returns & Fees
MeasureBSVIBBEdgeHow it is measured
Return
Total return+60.9%+699.2%IBBPrice change plus distributions, reinvested.
Annualized+2.5%+11.2%IBBTotal return as a yearly rate.
Price return+2.0%+665.1%IBBPrice change alone, distributions left out.
Risk
Volatility2.3%22.9%BSVSpread of weekly returns, annualized. Lower is steadier.
Downside deviation1.6%16.0%BSVLike volatility, counting only weeks below the Treasury bill rate.
Max drawdown−8.1%−37.5%BSVDeepest fall from a high to the low after it.
Risk-adjusted
Sharpe0.400.51IBBReturn above Treasury bills per unit of volatility.
Sortino0.580.73IBBReturn above Treasury bills per unit of downside deviation.
Calmar0.300.30TieAnnualized return divided by the max drawdown.

Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 1,018 weekly returns. Cash rate: the 13-week Treasury bill.

What they share

0%

By the books each fund has filed, BSV and IBB hold 0% of their money in the same securities at the same weight. Holdings dated Sep 30, 2026 and Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first BSV IBB
Only in one fund ↓
Only in BSV
United States Treasury Note/Bond 1.70%
United States Treasury Note/Bond 1.32%
United States Treasury Note/Bond 1.09%
United States Treasury Note/Bond 0.86%
United States Treasury Note/Bond 0.86%
United States Treasury Note/Bond 0.83%
United States Treasury Note/Bond 0.83%
United States Treasury Note/Bond 0.78%
Only in IBB
GILEAD SCIENCES 8.56%
AMGEN INC 8.20%
VERTEX PHARMACEUTICALS 7.53%
REGENERON PHARMACEUTICALS 5.64%
MODERNA 5.29%
NATERA 3.85%
ARGENX SE ADR 3.42%
ILLUMINA INC 2.93%
Check overlap with more funds →

Side by side

BSV Vanguard Short-Term Bond ETF IBB iShares Biotechnology ETF
Where it sits Bond ETF Thematic ETF
What it is Tracks an index of Short-Term Bond Biotech
Total return, 1 year +1.0% +37.5%
Expense ratio 0.03% 0.44%
Holdings 3157 245
Net assets, BSV as of Sep 30, 2026 and IBB as of Oct 27, 2026 $45.4bn $11.0bn

BSV and IBB on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Client brief · page 1 of 2 Report BR-AFF8513457

BSV and IBB do different jobs. What does each one do in a portfolio?

  1. What each follows. BSV follows Bloomberg U.S. 1-5 Year Government/Credit Float Adjusted Index and IBB follows Biotech.
  2. Holdings in common. 0% of the weight is in the same securities (holdings dated Sep 30, 2026 and Oct 27, 2026).
  3. One-year total return. Over 1 year to Oct 28, 2026 BSV returned +1.0% and IBB +37.5% with distributions reinvested, a gap of 36.5 points.

Data as of Oct 28, 2026.

The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.

Your saved page · Privacy.

Alert

IBB flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
BSV

BSV tracks an index of Short-Term Bond. Over the year to Oct 28, 2026 it returned +1.0% with distributions reinvested. The prospectus expense ratio is 0.03% a year.

IBB

By weight, 40% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 50% of the fund across 245 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +37.5% with distributions reinvested.

Questions people ask

Are BSV and IBB in the same category?
BSV is a bond ETF and IBB is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, BSV or IBB?
In the year to Oct 28, 2026, with distributions reinvested, BSV returned +1.0% and IBB +37.5%.
Which is cheaper, BSV or IBB?
BSV is cheaper, by 0.41 percentage points a year. That is about $41 on $10,000 held for a year. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, BSV against IBB, data as of Oct 28, 2026. https://etfiq.com/compare/any/bsv-vs-ibb

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.